# Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

> **NCT01052623** · PHASE4 · UNKNOWN · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Ataxia Telangiectasia
- Growth Failure

## Interventions

- **DRUG:** Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate

## Key facts

- **NCT ID:** NCT01052623
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052623, "Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01052623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*